- Home
- LBRX vs SB Comparison
LBRX vs SB Comparison
Compare LBRX & SB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LBRX | SB |
|---|---|---|
| Founded | 2015 | 2007 |
| Country | United States | Monaco |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 563.2M | 520.9M |
| IPO Year | 2025 | 2008 |
Fundamental Metrics
Financial Performance| Metric | LBRX | SB |
|---|---|---|
| Price | $19.89 | $5.05 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $49.00 | $6.00 |
| AVG Volume (30 Days) | ★ 531.1K | 387.1K |
| Earning Date | 02-15-2026 | 02-17-2026 |
| Dividend Yield | N/A | ★ 4.12% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.37 |
| Revenue | N/A | ★ $274,661,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $13.74 |
| P/E Ratio | ★ N/A | $13.28 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $13.36 | $3.02 |
| 52 Week High | $23.15 | $5.54 |
Technical Indicators
Market Signals| Indicator | LBRX | SB |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 60.56 |
| Support Level | N/A | $4.79 |
| Resistance Level | N/A | $4.88 |
| Average True Range (ATR) | 0.00 | 0.09 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 0.00 | 100.00 |
Price Performance
Historical ComparisonAbout LBRX LB Pharmaceuticals Inc
LB Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing novel therapies for the treatment of schizophrenia, bipolar depression, and other neuropsychiatric diseases. It is building a pipeline that leverages the broad therapeutic potential of its lead product candidate, LB-102, which the company believes has the potential to be the first benzamide antipsychotic drug approved for neuropsychiatric disorders in the United States. LB-102 is a new chemical entity and a methylated derivative of amisulpride, a second-generation antipsychotic drug approved in over 50 countries.
About SB Safe Bulkers Inc ($0.001 par value)
Safe Bulkers Inc is an international provider of marine drybulk transportation services, transporting bulk cargoes, particularly coal, grain and iron ore, along international shipping routes for consumers of marine drybulk transportation services. The company employs its vessels on both period time charters and spot time charters, according to the assessment of market conditions, with consumers of marine drybulk transportation services.